Gene Vector

Our state-of-the-art 3rd generation proprietary lentiviral vector is an extremely efficient gene transfer system for efficient and stable addition of genes to pre-selected patient cells. In addition, it has a high gene pay-load capacity capable of carrying multiple genes concurrently. Importantly, the FDA, EMA, Health Canada and other regulatory authorities are now gaining significant experience in reviewing and understanding the substantial safety and efficacy record associated with this gene transfer system. The first lentiviral gene therapy is now approved in Europe, with many more in clinical development across multiple disease states.

Gene Vector